Mode
Text Size
Log in / Sign up

Combined sleep and circadian interventions improve depressive symptoms and sleep quality in adults with mental disordersSleep and Circadian Interventions May Ease Depressive Symptoms

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider combined sleep and circadian interventions to improve depressive symptoms and sleep quality in adults with mental disorders.

This systematic review and meta-analysis evaluates the efficacy of non-pharmacological interventions targeting sleep and circadian rhythms in adults with mental disorders, including depressive disorders, bipolar disorder, and ADHD. The analysis synthesized data on several outcomes, finding that combined interventions significantly reduced depressive symptom severity (SMD = -0.51; 95% CI: -0.72 to -0.30) and improved sleep quality (SMD = -0.92; 95% CI: -1.19 to -0.65). Additionally, the intervention showed a higher treatment response rate (RR = 1.68; 95% CI: 1.25 to 2.27) and favored remission (RR = 2.06; 95% CI: 1.09 to 3.90).

Secondary outcomes also showed significant improvements, including insomnia severity (MD = -5.23), sleep-related impairment (MD = -7.91), and functional impairment (MD = -4.78). However, the authors note that some outcomes were supported by only a few trials, and the remission estimate was based on only two trials.

Limitations include significant heterogeneity in both diagnoses and specific interventions used across studies. The evidence certainty ranges from very low to moderate. These findings should be viewed as promising transdiagnostic evidence, but larger trials with longer follow-up periods are required to confirm these associations.

How this fits prior evidence

This meta-analysis addresses a gap in non-pharmacological management for mental disorders by evaluating sleep and circadian interventions. While previous coverage has identified specific biological pathways for cognitive heterogeneity in schizophrenia and bipolar disorder, this study provides evidence that targeting sleep and circadian rhythms may improve symptoms and functioning across multiple conditions including depressive disorders and ADHD.

Researchers analyzed a variety of non-pharmacological treatments that focus on sleep and the body's internal clock. The study looked at adults with several conditions, including depressive disorders, bipolar disorder, and attention-deficit/hyperactivity disorder. These types of interventions aim to stabilize sleep patterns and improve overall well-being.

The findings suggest that these sleep-focused methods can reduce the severity of depressive symptoms. The data also showed improvements in sleep quality, less sleep-related impairment, and better daily functioning for those involved. Some results even suggested a higher rate of remission for patients with mental health conditions.

Because this was a meta-analysis, it is important to note that the evidence varies in certainty. Some specific findings were based on only a few trials, and there was a lot of variety in the types of diagnoses and treatments studied. These results are promising but should be viewed as early evidence for several different conditions.

What this means for you:
Sleep and circadian interventions may improve mood and sleep quality for adults with various mental health disorders.

Common questions

What conditions can these sleep interventions help?

These non-pharmacological interventions were studied in adults with several mental health conditions. This includes depressive disorders, bipolar disorder, attention-deficit/hyperactivity disorder, and other mixed psychiatric samples.

How do these treatments affect sleep quality?

The results showed that interventions targeting sleep and circadian rhythms improved sleep quality and reduced sleep-related impairment. They also helped decrease the severity of insomnia for those in the study.

How much did symptoms improve?

The analysis showed a reduction in depressive symptom severity and an improvement in functional impairment. However, some results were based on only a few trials, so the evidence is currently viewed as promising rather than definitive.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
ObjectiveSleep disturbance and circadian rhythm dysregulation are common in mental disorders and may contribute to depressive symptoms and functional impairment. This systematic review and meta-analysis assessed the impact of non-pharmacological interventions targeting sleep and circadian rhythms on depressive symptoms and sleep-related outcomes in adults experiencing mental disorders.MethodsA comprehensive search was conducted across several databases, including PubMed, Embase, Web of Science, the Cochrane Library, CNKI, VIP, and Wanfang, covering the period from their inception until April 12, 2026. Eligible studies were randomized controlled trials (RCTs) of adults with clinically diagnosed mental disorders receiving combined sleep–circadian interventions. The included populations covered depressive disorders, bipolar disorder, severe mental illness, attention-deficit/hyperactivity disorder, and mixed psychiatric samples. Risk of bias was assessed using the Cochrane RoB 2 tool, and evidence certainty was rated using the GRADE approach. Meta-analyses were carried out with the aid of Review Manager version 5.4. Depending on the context, standardized mean differences (SMDs), mean differences (MDs), or risk ratios (RRs) along with 95% confidence intervals (CIs) were computed.ResultsEleven RCTs were included. Sleep–circadian interventions were associated with reduced depressive symptom severity (SMD = -0.51, 95% CI: -0.72 to -0.30) and higher treatment response (RR = 1.68, 95% CI: 1.25 to 2.27). Remission also favored the intervention groups, but this estimate was based on only two trials (RR = 2.06, 95% CI: 1.09 to 3.90). Improvements were observed in insomnia severity (MD = -5.23, 95% CI: -6.41 to -4.04), sleep disturbance or sleep quality (SMD = -0.92, 95% CI: -1.19 to -0.65), sleep-related impairment (MD = -7.91, 95% CI: -9.89 to -5.93), and functional impairment (MD = -4.78, 95% CI: -6.42 to -3.15). Evidence certainty ranged from very low to moderate, and several outcomes were supported by few trials.ConclusionSleep–circadian interventions may improve depressive symptoms, selected sleep outcomes, and functioning in adults with mental disorders. Given the heterogeneity of diagnoses and interventions, these findings should be viewed as promising transdiagnostic evidence. Larger trials with longer follow-up are needed.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO, identifier CRD420261412965.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.